Search

Your search keyword '"Bernstein, Jonine"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Bernstein, Jonine" Remove constraint Author: "Bernstein, Jonine" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
30 results on '"Bernstein, Jonine"'

Search Results

1. A genome-wide association study of contralateral breast cancer in the Women’s Environmental Cancer and Radiation Epidemiology Study

5. Mammographic texture features associated with contralateral breast cancer in the WECARE Study

6. First international workshop of the ATM and cancer risk group (4-5 December 2019)

7. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study

8. Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21

9. Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma

10. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI

11. Glioma-related seizures in relation to histopathological subtypes: a report from the glioma international case–control study

12. Impact of atopy on risk of glioma: a Mendelian randomisation study

13. Influence of obesity-related risk factors in the aetiology of glioma

14. Mendelian randomisation study of the relationship between vitamin D and risk of glioma

15. Targeted Sequencing in Chromosome 17q Linkage Region Identifies Familial Glioma Candidates in the Gliogene Consortium

17. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status

18. Erratum to: Survey of familial glioma and role of germline p16 INK4A /p14 ARF and p53 mutation

19. Survey of familial glioma and role of germline p16 INK4A /p14 ARF and p53 mutation

21. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study

22. Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study

25. ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay

26. CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study

27. The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study

28. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population

Catalog

Books, media, physical & digital resources